The first demonstration with Ozilia® Migraine was conducted yesterday at King Abdulaziz Medical City, a National Guard hospital in Jeddah. The company's distributor, Janin Medical, has been preparing for the launch since this spring – and this marks the first step after receiving market approval from the SFDA (Saudi Food and Drug Authority) a week ago.
King Abdulaziz Medical City, with 751 beds, is a significant part of the Ministry of National Guard Health Affairs' approximately 3,000+ beds across the kingdom, responsible for the healthcare of National Guard personnel and their families. Out of the country’s nearly 500 hospitals, about 335 are publicly owned or belong to various defense ministries, with the remainder being privately operated. The demonstration was carried out at the department of Dr. Abdullah Attar, head of neuroscience, by Janin’s sales manager Mohamad Ibrahim and Chordate’s General Manager Alain Durante, based in Jeddah.
"It’s a great feeling to finally get started after a period of preparation for the migraine introduction, and that we managed to secure product registration faster than expected," says Alain Durante, Chordate General Manager, MEA area.
